Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 23 articles:
HTML format



Single Articles


    August 2024
  1. GRIFFIN H, Ceron-Gutierrez L, Gharahdaghi N, Ebrahimi S, et al
    Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
    N Engl J Med. 2024;391:434-441.
    PubMed     Abstract available


    July 2024
  2. ABRAHAM C
    Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation.
    N Engl J Med. 2024;391:275-277.
    PubMed    


  3. PEYRIN-BIROULET L, Chapman JC, Colombel JF, Caprioli F, et al
    Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
    N Engl J Med. 2024;391:213-223.
    PubMed     Abstract available


    August 2023

  4. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2023;389:772.
    PubMed    


    June 2023
  5. D'HAENS G, Dubinsky M, Kobayashi T, Irving PM, et al
    Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2023;388:2444-2455.
    PubMed     Abstract available


    May 2023
  6. ABREU MT
    JAK1 Inhibition to Treat Crohn's Disease.
    N Engl J Med. 2023;388:2005-2009.
    PubMed    


  7. LOFTUS EV JR, Panes J, Lacerda AP, Peyrin-Biroulet L, et al
    Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
    N Engl J Med. 2023;388:1966-1980.
    PubMed     Abstract available


    March 2023
  8. TRAVIS S, Silverberg MS, Danese S, Gionchetti P, et al
    Vedolizumab for the Treatment of Chronic Pouchitis.
    N Engl J Med. 2023;388:1191-1200.
    PubMed     Abstract available


    April 2022
  9. KOTHARI R, Vashisht D
    Knife-Cut Ulcers in Crohn's Disease.
    N Engl J Med. 2022;386:e37.
    PubMed    


    January 2022
  10. ZANGER K, Nimkin K, Israel EJ, Shih AR, et al
    Case 3-2022: A 14-Year-Old Boy with Fever, Joint Pain, and Abdominal Cramping.
    N Engl J Med. 2022;386:375-383.
    PubMed    


  11. SANDBORN WJ, Danese S
    Ozanimod for Ulcerative Colitis. Reply.
    N Engl J Med. 2022;386:194-195.
    PubMed    


  12. SENUSSI NH, Rakov N
    Ozanimod for Ulcerative Colitis.
    N Engl J Med. 2022;386:194.
    PubMed    


  13. MACALUSO FS, Orlando A
    Ozanimod for Ulcerative Colitis.
    N Engl J Med. 2022;386:194.
    PubMed    


    November 2021
  14. PETRUZZI M, Della Vella F
    Pyostomatitis Vegetans.
    N Engl J Med. 2021;385:e77.
    PubMed    


    September 2021
  15. BAUMGART DC, Le Berre C
    Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease.
    N Engl J Med. 2021;385:1302-1315.
    PubMed    


  16. SANDBORN WJ, Feagan BG, D'Haens G, Wolf DC, et al
    Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2021;385:1280-1291.
    PubMed     Abstract available


    August 2021
  17. SCHETT G, McInnes IB, Neurath MF
    Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs.
    N Engl J Med. 2021;385:628-639.
    PubMed    


    April 2021
  18. CHANG JT
    Pathophysiology of Inflammatory Bowel Diseases. Reply.
    N Engl J Med. 2021;384:1378.
    PubMed    


  19. MRAVEC B
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1377-1378.
    PubMed    


  20. GAFFNEY P, Gaffney R
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1377.
    PubMed    


  21. CHEN CJ, Hu H, Liao WT
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1376-1377.
    PubMed    


    February 2021
  22. THOMAS AS, Ma W, Wang Y
    Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors.
    N Engl J Med. 2021;384:581-583.
    PubMed    


    December 2020
  23. CHANG JT
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2020;383:2652-2664.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.